A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…
Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.